Glaxosmithkline Biologicals SA vs. Pfizer Trading Polska Sp. Z.o.o.
UPC-CFI-0001511/2025
Case Details
Case Number
UPC-CFI-0001511/2025
Patent Number
Filing Date
2025-11-10
Proceeding Type
Counter claim for revocation
Case Phase
Oral Phase
Case Decision Date
1 April, 2026
Court Division
The Hague (NL) Local Division
Parties & Representative
Claimants
Represented By
3 Representatives ListedRepresentative
Representative
Representative
Defendants
Pfizer Trading Polska Sp. Z.o.o.
Pfizer Manufacturing Belgium NV
Biontech SE
Pfizer Hellas A.E.
Pfizer AB
Pfizer SA/NV
Pfizer Polska Sp. Z.o.o.
Pfizer Service Company B.V./SRL
Pfizer S AS
Pfizer Croatia D.o.o.
C.P. Pharmaceuticals International CV
Pfizer, Spol. S.r.o.
Pfizer Export B.V.
Biontech Europe GmbH
Pfizer Gyogyszerkereskedelmi Kft.
Biontech Manufacturing Marburg GmbH
Pfizer Luxembourg SARL
Pfizer Romania SRL
Pfizer Pharma GmbH
Laboratorios Pfizer, Lda.
Pfizer Corporation Austria Gesellschaft m.b.H
Pfizer Oy
Biontech Manufacturing GmbH
Represented By
3 Representatives ListedRepresentative
Representative
Representative
Court & Judges
Court / Division
The Hague (NL) Local Division
Judges
Edger Brinkman
Margot Kokke
Stefan Schilling
Martin Schmidt
Patents Involved
There is a single patent involved in this case.
| Application Number | Patent Number | External Links |
|---|---|---|
| - | EP2590626 |
Docket Entries
Cover sheet
2025-11-11
No Actions
Fee
2025-11-11
No Actions
Statement of defence
2025-11-11
No Actions
Exhibit document Defendant
2025-11-11
No Actions
Exhibit document Defendant
2025-11-11
No Actions